167 related articles for article (PubMed ID: 17108735)
1. [A case of gemcitabine-based chemo-radiation therapy for locally advanced unresectable pancreatic cancer].
Shinchi H; Takao S; Maemura K; Noma H; Kitazono M; Ueno S; Sakoda M; Kubo F; Aikou T
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1653-6. PubMed ID: 17108735
[TBL] [Abstract][Full Text] [Related]
2. [A case of advanced pancreatic cancer responding well to S-1/gemcitabine combination therapy after gemcitabine therapy].
Kuji M; Yamamoto Y; Tani C; Kenno S; Kobayashi T
Gan To Kagaku Ryoho; 2011 May; 38(5):853-5. PubMed ID: 21566453
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer.
Mishra G; Butler J; Ho C; Melin S; Case LD; Ennever PR; Magrinat GC; Bearden JD; Minotto DC; Howerton R; Levine E; Blackstock AW
Am J Clin Oncol; 2005 Aug; 28(4):345-50. PubMed ID: 16062075
[TBL] [Abstract][Full Text] [Related]
4. S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer.
Ke QH; Zhou SQ; Yang JY; Du W; Liang G; Lei Y; Luo F
World J Gastroenterol; 2014 Oct; 20(38):13987-92. PubMed ID: 25320537
[TBL] [Abstract][Full Text] [Related]
5. [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine as second-line chemotherapy].
Kawamoto K; Yamaguchi K; Okabe M; Tsuruta A; Morimoto Y; Niwano M; Sano K; Paku T; Imai S; Yoshida Y; Ito T; Ogasahara K
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1131-4. PubMed ID: 17637556
[TBL] [Abstract][Full Text] [Related]
6. A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer.
Martenson JA; Vigliotti AP; Pitot HC; Geeraerts LH; Sargent DJ; Haddock MG; Ghosh C; Keppen MD; Fitch TR; Goldberg RM
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1305-10. PubMed ID: 12654442
[TBL] [Abstract][Full Text] [Related]
7. Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.
Shoji H; Morizane C; Sakamoto Y; Kondo S; Ueno H; Takahashi H; Ohno I; Shimizu S; Mitsunaga S; Ikeda M; Okusaka T
Jpn J Clin Oncol; 2016 Feb; 46(2):132-7. PubMed ID: 26685318
[TBL] [Abstract][Full Text] [Related]
8. [A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with gemcitabine hydrochloride, 5-FU, CDDP and administration of tegafur/uracil].
Ishikawa T; Mizuno K; Watanabe K; Baba Y; Oota H; Yoshida T; Kamimura T
Gan To Kagaku Ryoho; 2004 Oct; 31(10):1555-8. PubMed ID: 15508450
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.
Haddock MG; Swaminathan R; Foster NR; Hauge MD; Martenson JA; Camoriano JK; Stella PJ; Tenglin RC; Schaefer PL; Moore DF; Alberts SR
J Clin Oncol; 2007 Jun; 25(18):2567-72. PubMed ID: 17577035
[TBL] [Abstract][Full Text] [Related]
10. [A case of locally advanced pancreatic cancer successfully resected after gemcitabine+S-1 therapy].
Moriyama M; Sawada S; Matsui K; Yoshioka I; Shibuya K; Osawa S; Yoshida T; Nagata T; Tsukada K
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2187-9. PubMed ID: 25731465
[TBL] [Abstract][Full Text] [Related]
11. Retrospective study of gemcitabine plus S-1 versus gemcitabine alone in cases with unresectable advanced pancreatic cancer.
Suzuki S; Ozaki Y; Saida S; Kaji S; Koike N; Harada N; Hayashi T; Suzuki M
Hepatogastroenterology; 2013 Jun; 60(124):916-20. PubMed ID: 23478143
[TBL] [Abstract][Full Text] [Related]
12. [A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy].
Ohta H; Doi T; Kikuchi S; Sato Y; Okuda T; Fujimi A; Kanisawa Y; Izumi K; Kitahara T
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1489-92. PubMed ID: 17876153
[TBL] [Abstract][Full Text] [Related]
13. A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.
Goji T; Kimura T; Miyamoto H; Takehara M; Kagemoto K; Okada Y; Okazaki J; Takaoka Y; Miyamoto Y; Mitsui Y; Matsumoto S; Sueuchi T; Tanaka K; Fujino Y; Takaoka T; Kitamura S; Okamoto K; Kimura M; Sogabe M; Muguruma N; Okahisa T; Sato Y; Sagawa T; Fujikawa K; Sato Y; Ikushima H; Takayama T
Cancer Chemother Pharmacol; 2015 Sep; 76(3):615-20. PubMed ID: 26220846
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study).
Ozaka M; Matsumura Y; Ishii H; Omuro Y; Itoi T; Mouri H; Hanada K; Kimura Y; Maetani I; Okabe Y; Tani M; Ikeda T; Hijioka S; Watanabe R; Ohoka S; Hirose Y; Suyama M; Egawa N; Sofuni A; Ikari T; Nakajima T
Cancer Chemother Pharmacol; 2012 May; 69(5):1197-204. PubMed ID: 22249272
[TBL] [Abstract][Full Text] [Related]
15. [A case of Complete Response(CR)to combination therapy of S-1 and Gemcitabine(GEM)for unresectable pancreatic cancer].
Miyagawa K; Yata Y; Yamaoka N; Sagara Y
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1145-7. PubMed ID: 20567125
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer.
Lee J; Park JO; Kim WS; Lee SI; Song SY; Lim DH; Choi SH; Heo JS; Lee KT; Lee JK; Kim K; Jung CW; Im YH; Lee MH; Kang WK; Park K
Oncology; 2004; 66(1):32-7. PubMed ID: 15031596
[TBL] [Abstract][Full Text] [Related]
17. [Locally advanced pancreatic cancer that enlarged after administration of gemcitabine and responded to oral TS-1--a case report].
Tanaka S; Fujii M; Goubaru M; Ohta T; Ogata M; Makino Y
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1485-7. PubMed ID: 16227755
[TBL] [Abstract][Full Text] [Related]
18. [Local recurrence after surgical resection of pancreatic cancer effectively treated with combined chemoradiotherapy].
Obuchi T; Sasaki A; Shimooki O; Minakawa Y; Abe T; Nitta H; Otsuka K; Koeda K; Ikeda K; Wakabayashi G
Gan To Kagaku Ryoho; 2009 Jun; 36(6):991-4. PubMed ID: 19542722
[TBL] [Abstract][Full Text] [Related]
19. Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine.
Kornek GV; Pötter R; Selzer E; Schratter A; Ulrich-Pur H; Rogy M; Kraus G; Scheithauer W
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):665-71. PubMed ID: 11172947
[TBL] [Abstract][Full Text] [Related]
20. A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma.
Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakagawa N; Takahashi S; Ohge H; Sueda T
Cancer Chemother Pharmacol; 2017 Apr; 79(4):775-781. PubMed ID: 28293715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
